Developer docs
API playgroundTry for free, no card

Search company profiles

Parthenon Capital Partners

Full company profile

uuid00009xa

Namestring
Parthenon Capital Partners
Legal namestring
PCP Managers, L.P., PCP Managers II, L.P., PCR Managers, L.P., PCap Company, LLC (collectively operating as Parthenon Capital Partners)
Company typeenum
Private
Founded yearint
1998
Descriptiontext

Parthenon Capital Partners is a Boston-based, growth-focused private equity firm founded in 1998 that invests $100 million to $1 billion per transaction in management teams building franchise companies across three core sectors: Financial Services, Healthcare Solutions, and Business & Tech Services. The firm operates with $10 billion or more in capital commitments and a team of 40-plus investment professionals across three strategic U.S. offices in Boston, San Francisco, and Austin. Approximately 70% of its investments use buy-and-build strategies, and the firm has completed more than 60 platform acquisitions and more than 500 add-on acquisitions over the last 25-plus years.

Parthenon's investment process is research-driven and thesis-based: the firm studies niche subsectors for extended periods before deploying capital, then partners collaboratively with management teams rather than imposing a prescriptive operating-partner model. Its revenue model follows standard private equity economics, consisting of recurring management fees on committed capital (typically 1.5-2.0% annually) and carried interest (typically 20%) on fund profits above an 8% hurdle rate, with institutional limited partners (pension funds, endowments, family offices, and sovereign wealth funds) committing through a dedicated LP Portal. Notable active portfolio companies include KBRA (acquired 2021), Pavilion Payments (acquired 2023 for $415 million), MRO, Payroc, Zelis, Cherry Bekaert, AArete, Embark, and Elevate Patient Financial Solutions.

In addition to capital, Parthenon provides portfolio companies with senior-level strategic and operational resources across strategy, operations, commercial excellence, capital markets, human capital, FP&A, automation and AI, and M&A. The firm differentiates from competitors through deep sector niche expertise, long-term value creation orientation, and a non-prescriptive partnership model. Recent activity includes a January 2026 continuation fund for KBRA exceeding $1.7 billion (including $800-$900 million of new capital), multiple 2025 platform investments, and continued organizational build-out with new Principals and functional leadership hires.

Short descriptiontext

Parthenon Capital Partners is a Boston-based growth-focused private equity firm founded in 1998 that invests $100M-$1B in financial services, healthcare solutions, and business/tech services companies, primarily via buy-and-build strategies, managing $10B+ in capital commitments.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
private equity investment, growth-stage investments, middle-market buyouts, buy-and-build strategies, management partnership capital
Industry1 code
1Sector-Focused Venture Capital (Vertical Specialists)
CodeFSANAAADPrimaryYes
NAICS code3 codes
  • Other Financial Investment Activities5239
  • Securities, Commodity Contracts, and Other Financial Investments and Related Activities523
  • Miscellaneous Intermediation52391
SIC code1 code
  • Investment Advice6282
Product category
Private Equity / Growth Equity
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Management Fees
TypeSubscription Recurring
Description

Private equity firms typically charge management fees on committed capital under management, typically 1.5-2% annually. Parthenon has $10B+ in capital commitments.

parthenoncapital.com
2Carried Interest (Performance Fees)
TypeProfessional Services
Description

PE firms earn carried interest (typically 20%) on profits generated for LP investors above an 8% hurdle rate. This is the primary upside for the GP and aligns interests between management and investors.

parthenoncapital.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Parthenon Capital Partners is a growth-focused private equity firm that invests $100M–$1B per transaction in management teams and their companies across three core sectors: Financial Services, Healthcare Solutions, and Business & Tech Services. The firm provides both capital and operational resources to portfolio companies, executing buy-and-build strategies through platform acquisitions and add-on investments, while raising capital from institutional limited partners through closed-end funds.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 70% of investments are buy-and-build strategies demonstrating consistent execution of add-on acquisition model
+1 more record
Product overview1 text field

Parthenon Capital Partners is a growth-focused private equity firm that operates as a single, unified investment platform rather than a modular product architecture. The firm offers three core investment sector verticals: Financial Services, Healthcare Solutions, and Business & Tech Services. Their investment approach is characterized by research-driven thematic investing, sector niche expertise, and long-term value creation through strategic and operational resources. With over $10 billion in capital commitments, the firm typically invests $100 million to $1 billion per transaction, with 70% of investments being buy & build strategies. Notable active portfolio companies include AArete, BirchStreet, CardWorks, Cherry Bekaert, DaySmart, EdgeCo Holdings, Elevate, Embark, KBRA, MRO, Pavilion Payments, Payroc, Venbrook, and Zelis. The firm maintains three strategic offices in Boston, San Francisco, and Austin and has completed over 60 platform and 500 add-on acquisitions since its founding in 1998.

Product and service5 records
1Financial Services Investment
CategoryPrivate Equity Investment Vertical
Description

Growth-stage private equity investments in financial services companies utilizing technology and information to reduce customer abrasion, compete effectively and manage dynamic regulatory environments. Target subsectors include financial software and analytics, integrated payments, insurance services, brokers and exchanges, wealth and asset management, capital markets software, specialty lending, collections, and employee benefits.

2Healthcare Solutions Investment
CategoryPrivate Equity Investment Vertical
Description

Growth-stage private equity investments in healthcare companies seeking to reduce cost, improve quality, access and outcomes while reducing friction. Target subsectors include HCIT, RCM, practice management and technology, data capture and analytics, healthcare payments, payor outsourcing, patient engagement, life sciences tech, pharmacy services, supply chain, coordination of care, benefits administration, and health insurance.

3Business & Tech Services Investment
CategoryPrivate Equity Investment Vertical
Description

Growth-stage private equity investments in business and tech services companies leveraging technology, data and business intelligence to enable customers to improve productivity, innovation and time to market. Target subsectors include human capital management, business process outsourcing, government and education, SaaS models, professional services, legal/regulatory services, IT and managed services, and data center services.

4Growth Investment Capital
CategoryPrivate Equity Capital
Description

Growth capital funding with transactional range of $100M to $1B, focusing on 70% buy-and-build strategies. Parthenon has completed over 60 platform acquisitions and 500+ add-on acquisitions over 25+ years, deploying capital into management teams and their companies.

5Portfolio Company Value Creation Services
CategoryAdvisory and Operational Support
Description

Strategic and operational resources provided to portfolio companies, including senior-level professionals in strategy and operations, commercial excellence, capital markets, human capital, FP&A, automation and AI, and M&A support. These services complement and supplement portfolio company management teams to drive value creation.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

GTCR is a leading middle-market PE firm with a Leaders Strategy approach; Parthenon's CIO William Kessinger was a former GTCR partner. Both firms target growth-oriented services and financial services businesses through sector specialization.

TypeDirect peer
Description

Audax is a middle-market private equity firm with a buy-and-build model that frequently co-invests with Parthenon (e.g., Elevate Patient Financial Solutions). Its sector focus and transaction size ($10M-$250M) overlap with Parthenon's lower end.

TypeDirect peer
Description

WCAS is a sector-focused middle-market PE firm concentrating on healthcare and technology services, directly overlapping with two of Parthenon's three core verticals and competing for similar platform deals.

TypeDirect peer
Description

Nautic Partners is a middle-market PE firm focused on services-related businesses; multiple Parthenon professionals previously worked at Nautic, evidencing the comparable investment orientation and target profile.

TypeBroad incumbent
Description

TPG is a global alternative asset manager; its TPG Growth middle-market/growth equity arm (e.g., seller of Q-Centrix to Parthenon's MRO) competes for and transacts with Parthenon at the upper end of its deal range, with broader sector and geographic reach.

TypeEmerging player
Description

M33 Growth is a Boston-based growth equity firm investing in technology-enabled business services companies — a smaller, emerging player with narrower geographic and sector focus than Parthenon but overlapping in target subsectors.

TypeDirect peer
Description

Great Point Partners is a healthcare-focused middle-market PE firm; Parthenon analysts have prior Great Point experience, reflecting comparable transaction sizes and subsector focus on healthcare services and pharma services.

TypeDirect peer
Description

Lightview Capital is a middle-market growth equity firm investing in tech-enabled business services and healthcare — directly comparable to Parthenon's Business & Tech Services and Healthcare Solutions verticals.

TypeDirect peer
Description

Berkshire Partners is a Boston-based middle-market PE firm investing in consumer, retail, services, and technology-enabled businesses — overlapping with Parthenon's business services and healthcare verticals.

TypeDirect peer
Description

TA Associates is a global growth private equity firm investing in profitable, growing companies in technology, healthcare, financial, and business services — directly overlapping with Parthenon's three sector verticals.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A9 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment47 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Parthenon Capital Partners

Private Equity / Growth Equityparthenoncapital.com

Parthenon Capital Partners is a Boston-based growth-focused private equity firm founded in 1998 that invests $100M-$1B in financial services, healthcare solutions, and business/tech services companies, primarily via buy-and-build strategies, managing $10B+ in capital commitments.

What Parthenon Capital Partners does

Parthenon Capital Partners is a Boston-based, growth-focused private equity firm founded in 1998 that invests $100 million to $1 billion per transaction in management teams building franchise companies across three core sectors: Financial Services, Healthcare Solutions, and Business & Tech Services. The firm operates with $10 billion or more in capital commitments and a team of 40-plus investment professionals across three strategic U.S. offices in Boston, San Francisco, and Austin. Approximately 70% of its investments use buy-and-build strategies, and the firm has completed more than 60 platform acquisitions and more than 500 add-on acquisitions over the last 25-plus years.

Parthenon's investment process is research-driven and thesis-based: the firm studies niche subsectors for extended periods before deploying capital, then partners collaboratively with management teams rather than imposing a prescriptive operating-partner model. Its revenue model follows standard private equity economics, consisting of recurring management fees on committed capital (typically 1.5-2.0% annually) and carried interest (typically 20%) on fund profits above an 8% hurdle rate, with institutional limited partners (pension funds, endowments, family offices, and sovereign wealth funds) committing through a dedicated LP Portal. Notable active portfolio companies include KBRA (acquired 2021), Pavilion Payments (acquired 2023 for $415 million), MRO, Payroc, Zelis, Cherry Bekaert, AArete, Embark, and Elevate Patient Financial Solutions.

In addition to capital, Parthenon provides portfolio companies with senior-level strategic and operational resources across strategy, operations, commercial excellence, capital markets, human capital, FP&A, automation and AI, and M&A. The firm differentiates from competitors through deep sector niche expertise, long-term value creation orientation, and a non-prescriptive partnership model. Recent activity includes a January 2026 continuation fund for KBRA exceeding $1.7 billion (including $800-$900 million of new capital), multiple 2025 platform investments, and continued organizational build-out with new Principals and functional leadership hires.

Parthenon Capital Partners firmographics

Firmographics
Name
Parthenon Capital Partners
Legal name
PCP Managers, L.P., PCP Managers II, L.P., PCR Managers, L.P., PCap Company, LLC (collectively operating as Parthenon Capital Partners)
Website
https://www.parthenoncapital.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
11–50 employees
Short description
Parthenon Capital Partners is a Boston-based growth-focused private equity firm founded in 1998 that invests $100M-$1B in financial services, healthcare solutions, and business/tech services companies, primarily via buy-and-build strategies, managing $10B+ in capital commitments.
Ownership category
akta.pro rank

Parthenon Capital Partners industry classification

Industry
Product category
Private Equity / Growth Equity
NAICS
Other Financial Investment Activities (5239), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523), Miscellaneous Intermediation (52391)
SIC
Investment Advice (6282)
akta.pro primary industry
Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

  • Private equity investment
  • Growth-stage investments
  • Middle-market buyouts
  • Buy-and-build strategies
  • Management partnership capital

Where Parthenon Capital Partners is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Parthenon Capital Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Management Fees: Private equity firms typically charge management fees on committed capital under management, typically 1.5-2% annually. Parthenon has $10B+ in capital commitments.
  2. Carried Interest (Performance Fees): PE firms earn carried interest (typically 20%) on profits generated for LP investors above an 8% hurdle rate. This is the primary upside for the GP and aligns interests between management and investors.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Parthenon Capital Partners product offering

Product offering

Core offering

Parthenon Capital Partners is a growth-focused private equity firm that invests $100M–$1B per transaction in management teams and their companies across three core sectors: Financial Services, Healthcare Solutions, and Business & Tech Services. The firm provides both capital and operational resources to portfolio companies, executing buy-and-build strategies through platform acquisitions and add-on investments, while raising capital from institutional limited partners through closed-end funds.

Product overview

Parthenon Capital Partners is a growth-focused private equity firm that operates as a single, unified investment platform rather than a modular product architecture. The firm offers three core investment sector verticals: Financial Services, Healthcare Solutions, and Business & Tech Services. Their investment approach is characterized by research-driven thematic investing, sector niche expertise, and long-term value creation through strategic and operational resources. With over $10 billion in capital commitments, the firm typically invests $100 million to $1 billion per transaction, with 70% of investments being buy & build strategies. Notable active portfolio companies include AArete, BirchStreet, CardWorks, Cherry Bekaert, DaySmart, EdgeCo Holdings, Elevate, Embark, KBRA, MRO, Pavilion Payments, Payroc, Venbrook, and Zelis. The firm maintains three strategic offices in Boston, San Francisco, and Austin and has completed over 60 platform and 500 add-on acquisitions since its founding in 1998.

Differentiator

Problem solved

Functional benefit

Products and services

  • Financial Services Investment Growth-stage private equity investments in financial services companies utilizing technology and information to reduce customer abrasion, compete effectively and manage dynamic regulatory environments. Target subsectors include financial software and analytics, integrated payments, insurance services, brokers and exchanges, wealth and asset management, capital markets software, specialty lending, collections, and employee benefits.
  • Healthcare Solutions Investment Growth-stage private equity investments in healthcare companies seeking to reduce cost, improve quality, access and outcomes while reducing friction. Target subsectors include HCIT, RCM, practice management and technology, data capture and analytics, healthcare payments, payor outsourcing, patient engagement, life sciences tech, pharmacy services, supply chain, coordination of care, benefits administration, and health insurance.
  • Business & Tech Services Investment Growth-stage private equity investments in business and tech services companies leveraging technology, data and business intelligence to enable customers to improve productivity, innovation and time to market. Target subsectors include human capital management, business process outsourcing, government and education, SaaS models, professional services, legal/regulatory services, IT and managed services, and data center services.
  • Growth Investment Capital Growth capital funding with transactional range of $100M to $1B, focusing on 70% buy-and-build strategies. Parthenon has completed over 60 platform acquisitions and 500+ add-on acquisitions over 25+ years, deploying capital into management teams and their companies.
  • Portfolio Company Value Creation Services Strategic and operational resources provided to portfolio companies, including senior-level professionals in strategy and operations, commercial excellence, capital markets, human capital, FP&A, automation and AI, and M&A support. These services complement and supplement portfolio company management teams to drive value creation.

Quantifiable outcome

  • 70% of investments are buy-and-build strategies demonstrating consistent execution of add-on acquisition model
  • +1 more outcomes

Companies that use Parthenon Capital Partners

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Parthenon Capital Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Parthenon Capital Partners partnerships and signals

Strategic signal

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Parthenon Capital Partners competitors and assessment

Company assessment

Direct peers

  • GTCR: GTCR is a leading middle-market PE firm with a Leaders Strategy approach; Parthenon's CIO William Kessinger was a former GTCR partner. Both firms target growth-oriented services and financial services businesses through sector specialization.
  • Audax Private Equity: Audax is a middle-market private equity firm with a buy-and-build model that frequently co-invests with Parthenon (e.g., Elevate Patient Financial Solutions). Its sector focus and transaction size ($10M-$250M) overlap with Parthenon's lower end.
  • Welsh, Carson, Anderson & Stowe (WCAS): WCAS is a sector-focused middle-market PE firm concentrating on healthcare and technology services, directly overlapping with two of Parthenon's three core verticals and competing for similar platform deals.
  • Nautic Partners: Nautic Partners is a middle-market PE firm focused on services-related businesses; multiple Parthenon professionals previously worked at Nautic, evidencing the comparable investment orientation and target profile.
  • Great Point Partners: Great Point Partners is a healthcare-focused middle-market PE firm; Parthenon analysts have prior Great Point experience, reflecting comparable transaction sizes and subsector focus on healthcare services and pharma services.
  • Lightview Capital: Lightview Capital is a middle-market growth equity firm investing in tech-enabled business services and healthcare — directly comparable to Parthenon's Business & Tech Services and Healthcare Solutions verticals.
  • Berkshire Partners: Berkshire Partners is a Boston-based middle-market PE firm investing in consumer, retail, services, and technology-enabled businesses — overlapping with Parthenon's business services and healthcare verticals.
  • TA Associates: TA Associates is a global growth private equity firm investing in profitable, growing companies in technology, healthcare, financial, and business services — directly overlapping with Parthenon's three sector verticals.

Broad incumbents

  • TPG: TPG is a global alternative asset manager; its TPG Growth middle-market/growth equity arm (e.g., seller of Q-Centrix to Parthenon's MRO) competes for and transacts with Parthenon at the upper end of its deal range, with broader sector and geographic reach.

Emerging players

  • M33 Growth: M33 Growth is a Boston-based growth equity firm investing in technology-enabled business services companies — a smaller, emerging player with narrower geographic and sector focus than Parthenon but overlapping in target subsectors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Parthenon Capital Partners social profiles

Digital presence

Parthenon Capital Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Parthenon Capital Partners leadership team

Management profile

Number of profiles

Profiles11 records

Parthenon Capital Partners funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Parthenon Capital Partners M&A and investment

M&A and investment

M&A9 records

Investments47 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Parthenon Capital Partners

What does Parthenon Capital Partners do?

Parthenon Capital Partners is a growth-focused private equity firm that invests $100M–$1B per transaction in management teams and their companies across three core sectors: Financial Services, Healthcare Solutions, and Business & Tech Services. The firm provides both capital and operational resources to portfolio companies, executing buy-and-build strategies through platform acquisitions and add-on investments, while raising capital from institutional limited partners through closed-end funds.

Is Parthenon Capital Partners a public or private company?

Parthenon Capital Partners is a private company. It is classified as management employee owned and is currently operating.

When was Parthenon Capital Partners founded?

Parthenon Capital Partners was founded in 1998. It employs 11 to 50 people.

Where is Parthenon Capital Partners based?

Parthenon Capital Partners is headquartered in Boston, United States, in the North America region.

How does Parthenon Capital Partners make money?

Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest (Performance Fees).

Who are Parthenon Capital Partners's main competitors?

Direct peers on record are GTCR, Audax Private Equity, Welsh, Carson, Anderson & Stowe (WCAS), Nautic Partners, Great Point Partners, Lightview Capital, Berkshire Partners and TA Associates. TPG is listed as a broad incumbent. M33 Growth is listed as an emerging player.

Does Parthenon Capital Partners have an API?

No public API is recorded for Parthenon Capital Partners.

What industry is Parthenon Capital Partners in?

Parthenon Capital Partners's product category is Private Equity / Growth Equity. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 5239 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BloombergWhen 20% of Profits Won’t Do, Fund Managers Seek ‘Super Carry’Parthenon Capital Partners sought super carry to manage a new fund for its Kroll Bond Rating Agency stake, but multiple investors balked. HarbourVest Partners agreed, enabling Parthenon to raise over $1.7 billion for the single-asset continuation vehicle.BloombergWhen 20% of Profits Won’t Do, Fund Managers Seek ‘Super Carry’Parthenon Capital Partners sought super carry to manage a new fund for its Kroll Bond Rating Agency stake, but investors balked until HarbourVest agreed. The deal allowed Parthenon to raise over $1.7 billion for the single-asset continuation vehicle.Stock TitanREPAY adds Parthenon Capital partner Zach Sadek to boardRepay Holdings Corporation announced the appointment of Zachary F. Sadek, Senior Partner at Parthenon Capital Partners, to its Board of Directors, effective immediately. The appointment expands the board to seven directors, with six qualifying as independent under NASDAQ guidelines, and was made in connection with a cooperation agreement between the Company and Parthenon Capital following constructive engagement. Parthenon Capital, through its affiliate PCP Managers II L.P., is one of REPAY's largest stockholders.FinSMEsMomentum Life Sciences Receives Growth Investment From Parthenon CapitalMomentum Life Sciences, an Indianapolis-based commercialization platform for specialty therapies, received an undisclosed investment from Parthenon Capital. The company will use the funds to accelerate growth and pursue strategic acquisitions. The deal was led by CEO Andi Heslin Smiley.Pulse 2.0Momentum Life Sciences Receives Strategic Growth Investment From Parthenon CapitalMomentum Life Sciences announced a strategic growth investment from Parthenon Capital, a growth-oriented private equity firm with healthcare expertise. The financial terms of the transaction were not disclosed. The investment will provide Momentum with capital and strategic resources to accelerate its growth strategy and pursue strategic acquisitions aimed at expanding its platform that supports therapy initiation and adherence for specialty therapies.MomentumlsMomentum Life Sciences Announces Strategic Growth Investment from Parthenon CapitalMomentum Life Sciences announced a strategic investment from Parthenon Capital to accelerate its commercialization platform for specialty therapies. The investment will provide capital for growth and strategic acquisitions, with existing leadership remaining significant shareholders. The company aims to address adherence and access challenges for patients and providers.Insurance Business AmericaVenbrook turns to seasoned deal integration executive for CFO roleVenbrook Group has appointed Kenneth W. Ward as its new Chief Financial Officer, effective immediately, based in Milton, Georgia. Ward brings extensive experience in enterprise-level integrations, cost optimization, and M&A financial leadership from previous CFO roles at Centerline Communications, National Parts Warehouse, SUZOHAPP, and AGCO Corporation. His appointment aligns with Venbrook's ownership structure under Parthenon Capital and supports the company's ongoing growth and integration strategy following several recent senior hires and product expansions.BloombergParthenon Looks to Keep KBRA With $1.7 Billion Continuation FundParthenon Capital Partners is seeking to extend its ownership of credit rating agency Kroll Bond Rating Agency through a secondary continuation fund that could exceed $1.7 billion, with $800 million to $900 million of that representing new capital from investors. Lazard Inc. is advising Parthenon on the transaction, which would allow the private equity firm to hold KBRA beyond typical fund cycle timelines. The continuation fund structure is a common mechanism in private equity for extending investment periods on successful assets.PR NewswireEmbark Announces Strategic Investment from Parthenon Capital to Accelerate GrowthEmbark announced a strategic partnership with Parthenon Capital, a private equity firm, to accelerate growth. The investment will expand technology capabilities, particularly in automation and AI for CFO offices, and support talent acquisition. Embark's founder Paul Allen will remain chairman and lead the People & Culture Committee.GoodwinlawGoodwin Guides Frazier Healthcare Partners in Sale of Elevate Patient Financial Solutions to Audax Private Equity and Parthenon CapitalFrazier Healthcare Partners sold Elevate Patient Financial Solutions, a technology-enabled specialty revenue cycle management services provider headquartered in Spring, TX, to Audax Private Equity and Parthenon Capital. The transaction was guided by Goodwin's Private Equity team. Founded in 1991, Frazier Healthcare Partners has invested in over 200 companies across more than 33 years with over $11 billion of capital raised for private funds.